Pharmacogenomics (PGx) utilizes genetic information to optimize medication management. Barriers to PGx implementation include limited confidence and knowledge in applying results, time constraints, and financial barriers. Clinical services across health systems vary greatly with differing consultative PGx service models. Most research on clinicians and PGx has been centered around attitudes and perspectives, with limited data regarding clinician satisfaction with PGx clinical services. An internally developed survey was created to assess clinician satisfaction with PGx services across a single health system. A survey was deployed to 645 clinicians (physicians, advanced practice providers, and genetic counselors) who utilized PGx clinical services (ordered PGx testing or a referral to the PGx clinic) within the past 3 years. Surveys were distributed via secure email in June 2025. A total of 36 out of 645 clinicians participated in the survey, which is noted as a limitation. Respondents tended to be satisfied ("somewhat satisfied" or "very satisfied") across several clinical service domains (e.g., process of ordering PGx testing, integration into the electronic health record, and return of PGx results). Pharmacist notes and clinical decision support yielded the highest satisfaction. Most clinicians reported PGx results have positively impacted patient outcomes. Nearly half of respondents noted experiencing barriers in explaining PGx results to patients. The PGx clinic may help mitigate barriers in explaining PGx results to patients. Overall, responding clinicians were satisfied with the majority of PGx clinical services.
Jacobsen et al. (Sun,) studied this question.